Pfizer CEO Albert Bourla sold 60 percent of his stock in the drug company for $5.6 million Monday - the same day the firm announced its COVID-19 vaccine breakthrough. Bourla sold 132,508 shares at $41.94 per share, according to a Securities and Exchange Commission filing late Tuesday. Shares in Pfizer hit $41.99 Monday, its highest point in a year and up 15 per cent on the day. Bourla sold off just shy of that peak. Bourla sold off just shy of that peak.
